<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Fourteen Newly Recognized Proteins at the Human Neuromuscular Junctions-and Their Nonjunctional Accumulation in Inclusion-Body Myositisaa</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Wiley</publisher>
				<availability status="unknown"><p>Copyright Wiley</p>
				</availability>
				<date type="published" when="1998-05">1998-05</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Valerie</forename><surname>Askanas</surname></persName>
						</author>
						<author>
							<persName><forename type="first">W</forename><forename type="middle">King</forename><surname>Engel</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Renate</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="institution">by University Of Illinois At Urbana Champaign</orgName>
								<address>
									<addrLine>Wiley Online Library on [05</addrLine>
									<country>03</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department">USC Neuromuscular Center Department of Neurology</orgName>
								<orgName type="institution">University of Southern California School of Medicine Good Samaritan Hospital Los Angeles</orgName>
								<address>
									<postCode>90017-1912</postCode>
									<region>California</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="institution">by University Of Illinois At Urbana Champaign</orgName>
								<address>
									<addrLine>Wiley Online Library on [05</addrLine>
									<country>03</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Fourteen Newly Recognized Proteins at the Human Neuromuscular Junctions-and Their Nonjunctional Accumulation in Inclusion-Body Myositisaa</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Annals of the New York Academy of Sciences</title>
						<title level="j" type="abbrev">Annals NY Acad Sci</title>
						<idno type="ISSN">0077-8923</idno>
						<idno type="eISSN">1749-6632</idno>
						<imprint>
							<publisher>Wiley</publisher>
							<biblScope unit="volume">841</biblScope>
							<biblScope unit="issue">1 MYASTHENIA GR</biblScope>
							<biblScope unit="page" from="28" to="56"/>
							<date type="published" when="1998-05" />
						</imprint>
					</monogr>
					<idno type="MD5">4AEECA09550FAE3CA4E344A401E561AC</idno>
					<idno type="DOI">10.1111/j.1749-6632.1998.tb10908.x</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2" ident="GROBID" when="2023-03-30T18:12+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>The neuromuscular junction (NMJ), the synapse between a distal axonal tip of a lower motor neuron and a muscle fiber, is a highly specialized and complicated structure. At the NMJ, the molecular composition of the muscle-fiber extracellular matrix, the plasmalemma, and the immediately postsynaptic cytoplasmic domain is distinctly different from that of the nonsynaptic regions of the same muscle fiber (reviewed in references 1-6). In general, the postsynaptic proteins may be classified as those localized to the synaptic basal lamina, the plasmalemma, or the subplasmalemmal cytoskeleton. <ref type="bibr" target="#b0">[1]</ref><ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref> In virtually all species including human, the most characteristic feature of the postsynaptic plasmalemma is the high concentration of nicotinic acetylcholine receptors (AChRs). During the last two decades, considerable progress has been made in identifying mechanisms causing AChR clustering at the NMJ. <ref type="bibr" target="#b0">[1]</ref><ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref> More than a dozen other proteins that either are present only at the postsynaptic domain of the NMJ or are highly concentrated there have been identified in various species (reviewed in reference 4). Remaining largely unknown are (a) the function of many of them, (b) how and why they are assembled at the NMJ, and (c) a possible pathologic role in NMJ disorders.</p><p>During the last several years, we have studied the molecular pathogenesis of sporadic inclusion-body myositis (s-IBM) and the hereditary inclusion-body myopathies (h-IBMs) (reviewed in references 7 and 8). These diseases, formerly underdiagnosed and considered infrequent syndromes, are now identified more and more often by clinicians and pathologists. Recent interest in s-and h-IBMs has been generated by the identification of abnormal accumulation within IBM muscle fibers of the group of diverse proteins previously considered characteristic of Alzheimer-disease brain and thought not to occur in diseased human muscle. <ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b7">8</ref> It is particularly germane that nearly all the proteins that we have found abnormally accumulated within the IBM muscle fibers are, in normal human muscle, accumulated only at the postsynaptic domain of the NMJ (TABLE <ref type="table">1</ref>).</p><p>Those proteins include ␤-amyloid protein (A␤), 9 two other (C-and N-terminal) 28</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>epitopes of the ␤-amyloid precursor protein (␤APP), <ref type="bibr" target="#b9">10</ref> ␣ 1 -antichymotrypsin (␣ 1 -ACT), <ref type="bibr" target="#b12">13</ref> apolipoprotein E (ApoE), <ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b14">15</ref> ubiquitin, <ref type="bibr" target="#b15">16</ref> and cellular prion protein (PrP). <ref type="bibr" target="#b16">17</ref> Those proteins were previously considered strictly neuronal and characteristic of Alzheimer's disease (AD) and prion brain diseases. The accumulation of ␤APP and prion at the postsynaptic NMJ results, at least partially, from their locally increased synthesis there, evidenced by their junctionally increased mRNAs; <ref type="bibr" target="#b17">18,</ref><ref type="bibr" target="#b18">19</ref> these same two mRNAs are also increased, along with increased SOD1-mRNA (see below), in IBM muscle fibers exhibiting increases of their corresponding proteins.</p><p>Also abnormally accumulated within IBM muscle fibers are neuronal and inducible nitric oxide synthase, <ref type="bibr" target="#b23">24</ref> transforming growth factor ␤1, <ref type="bibr" target="#b24">25</ref> fibroblast growth factor (FGF), <ref type="bibr" target="#b26">26</ref> and interleukins 1␣, 1␤, and 6, <ref type="bibr" target="#b27">27</ref> all of which are likewise accumulated at normal human NMJs. Moreover, nicotinic acetylcholine receptor (AChR) and its mRNA, and 43-kDa protein (rapsyn), which are known junctional proteins, are also abnormally accumulated within the IBM muscle. <ref type="bibr" target="#b28">28</ref> The only protein that is abnormally accumulated in the IBM muscle, but not accumulated at the NMJ is hyperphosphorylated tau. <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b11">12</ref> In this article, we describe examples of these 14 novel proteins accumulated at human NMJs. So far, their functions and the mechanisms controlling their expression at the NMJ are not known. Although an important contributory pathologic role of any of these proteins in disorders of the NMJ/neuromuscular transmission has not yet been identified, it can be contemplated in the various NMJ disorders, including myasthenia gravis.</p><p>We also present our hypothesis regarding a possible mechanism for the accumulation of these "junctional proteins" within nonjunctional regions of IBM muscle fibers.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>␤-AMYLOID PRECURSOR PROTEIN (␤APP)</head><p>Background ␤APP, a product of a chromosome-21 gene (reviewed in reference 29), exists in virtually all tissues. ␤APP is a glycoprotein cell-surface component containing a large extracellular N-terminus domain, a transmembrane domain, and a short cytoplasmic carboxyl-terminus domain. <ref type="bibr" target="#b30">30,</ref><ref type="bibr" target="#b31">31</ref> The ␤APP gene produces at least three alternatively spliced transcripts encoding ␤APP, containing 695, 751, or 770 amino acids; the last two contain in their extracellular region an insert of a Kunitz-type protease inhibitor. <ref type="bibr" target="#b30">[30]</ref><ref type="bibr" target="#b31">[31]</ref><ref type="bibr" target="#b32">[32]</ref><ref type="bibr" target="#b33">[33]</ref><ref type="bibr" target="#b34">[34]</ref><ref type="bibr" target="#b35">[35]</ref> The biological functions of ␤APP are unknown, but it may play a role in mediating cell-to-cell and cell-to-matrix interaction, neurite growth, and maintenance of cell integrity and shape. <ref type="bibr" target="#b36">[36]</ref><ref type="bibr" target="#b37">[37]</ref><ref type="bibr" target="#b38">[38]</ref><ref type="bibr" target="#b39">[39]</ref> At central and peripheral synapses, its presynaptic localization was reported, <ref type="bibr" target="#b40">40</ref> although at the human NMJ we find it concentrated postsynaptically (see below). ␤-Amyloid protein (A␤) is a 39-42-residue polypeptide that is a part of ␤APP. <ref type="bibr" target="#b29">[29]</ref><ref type="bibr" target="#b30">[30]</ref><ref type="bibr" target="#b31">[31]</ref><ref type="bibr" target="#b41">41</ref> A␤ is the major component of amyloid fibrils in blood vessels and senile plaques in the brain of patients with Alzheimer's disease, Down syndrome, Dutch hereditary cerebrovascular amyloidosis, and very advanced age (reviewed in reference 29).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>NMJs</head><p>Using several well-characterized antibodies against various epitopes of ␤APP including A␤, we immunolocalized ␤APP at the NMJs of normal human muscle biopsies <ref type="bibr" target="#b42">42</ref> (FIGURE <ref type="figure" target="#fig_0">1</ref>). In all biopsies, all the NMJs identified by ␣-BT binding had very strong immunoreactivity with antibodies to all the ␤APP sequences studied (this suggests that, at normal junctions, A␤ immunoreactivity may be part of intact molecules of ␤APP). The muscle nonjunctional sarcolemma was very faintly immunoreactive with all antibodies. The C-␤APP (FIGURE <ref type="figure" target="#fig_0">1</ref>), A␤ (FIGURE <ref type="figure" target="#fig_0">1</ref>), and N-␤APP (not shown) immunoreactivities closely colocalized with the postsynaptic cytoplasmic ␣-BT, desmin, and dystrophin <ref type="bibr" target="#b42">42</ref> (FIGURE <ref type="figure" target="#fig_0">1</ref>).</p><p>By gold immunoelectron-microscopy (immuno-EM), ␤APP immunoreactivity was localized subjunctionally for a depth of 5-7 m, especially between junctional nuclei and the base of the junctional folds, and also throughout the folds (FIGURES 2 and 3). Most commonly, ␤APP was in amorphous patches up to 30-45 nm wide and in short filaments 5-8 nm wide. Because muscle intermediate-filament desmin is an established postsynaptic component of human NMJs <ref type="bibr" target="#b43">43</ref> (FIGURE <ref type="figure" target="#fig_1">4</ref>), we colocalized at human NMJs two ␤APP epitopes and desmin by gold immuno-EM, using 5-and 15- nm gold particles to simultaneously label ␤APP and desmin, respectively, on the same sections. Desmin was in short filaments about 10-12 nm wide and in larger amorphous patches up to 45-90 nm wide. Therefore, similarly to desmin, ␤APP appears to be an integral component of the postsynaptic cytoskeleton of human NMJs. In addition to being accumulated at the NMJ, ␤APP protein appears to be locally transcribed there as evidenced by in situ hybridization studies demonstrating increased accumulation of ␤APP-mRNA at the NMJs 18 (FIGURE <ref type="figure" target="#fig_2">5</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>FIGURE 2.</head><p>Gold immunoelectron-microscopy of ␤APP at the postsynaptic domain at human NMJs (5-nm gold particles), ×48,000. ␤APP is immunolocalized subjunctionally, between and below junctional folds on short filaments and small amorphous patches (dark round patches represent the labeling of AChE used to identify NMJs). In various animal species, shown to be transcribed at the NMJ were AChRs, acetylcholinesterase, neural cell-adhesion molecule (N-CAM) (reviewed in reference 4), and utrophin. <ref type="bibr" target="#b44">44</ref> Our studies of ␤APP were the first to demonstrate transcription of a protein at human NMJs. Recently, using in situ hybridization, we have also demonstrated increased transcription at human NMJs of AChR (FIGURE <ref type="figure" target="#fig_3">6</ref>) and prion protein (see below). The physiologic role of ␤APP at the NMJ is not understood, but speculatively ␤APP may be involved in the following: (a) maintaining stability and configuration of the postsynaptic membrane by associating with postsynaptic cytoskeletal components of the muscle fiber, for example, dystrophin and desmin; (b) maintaining adhesion between the postsynaptic and presynaptic components; (c) the interaction between the postsynaptic plasmalemma and basal lamina (and perhaps junction-FIGURE 3. Gold immunoelectron-microscopy of ␤APP and desmin at human NMJs. (A) ␤APP (5-nm gold particles); (B) double-labeling of ␤APP (5-nm gold particles) and desmin (15-nm gold particles). (A) ×85,000; (B) ×132,000. In A and B, ␤APP is immunolocalized mainly between the junctional folds and below the folds on short filaments 5-8 nm wide; in B, ␤APP is also immunolocalized on amorphous patches. Desmin is immunolocalized on short filaments 10-12 nm wide and amorphous patches 45-90 nm wide (B). al acetylcholinesterase); (d) inhibiting, by its Kunitz protease-inhibitor portion, excessive or unwanted serine proteases that may exist at the NMJ; (e) binding and internalization of synaptic substances (analogous to the demonstrated internalization of ␤APP/A␤ into lysosomes); or (f) signaling, during development, from muscle fiber to the approaching motor axon, a perturbation of which may occur in ␤APP-overexpressed muscle fibers (see below). The strong concentration of ␤APP at human NMJs also raises the possibility that it could have a pathogenic role in some diseases affecting NMJs, such as in some patients with myasthenia gravis.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>IBMs</head><p>We have reported pathologic accumulation of A␤ <ref type="bibr" target="#b8">9</ref> and two other ␤APP sequences 10 in nonjunctional regions of vacuolated muscle fibers of s-and h-IBMs.</p><p>Recently, we demonstrated that overexpression of ␤APP in normal cultured human muscle fibers interferes with proper innervation and formation of the NMJs 47    (the overexpression was achieved by direct transfer into the cultured muscle fibers of the ␤APP gene via a recombinant adenovirus vector <ref type="bibr" target="#b45">45,</ref><ref type="bibr" target="#b46">46</ref> ).</p><p>In our human-muscle rat-spinal-cord cocultures, the innervated human muscle fibers become fully cross-striated, are continuously and rhythmically contracting, and have acetylcholinesterase (AChE) and acetylcholine receptors (AChRs) accumulated only at the NMJs. <ref type="bibr" target="#b48">48,</ref><ref type="bibr" target="#b49">49</ref> By contrast, ␤APP-overexpressing cocultured muscle fibers apparently were not able to become properly innervated because (a) they were not cross-striated and not contracting; (b) AChE on them was in large and diffuse patches, and only 2-3% of the fibers had normal AChR clusters; and (c) axons outgrowing from the spinal cord explants had stopped when they contacted normal-control muscle fibers, but appeared to pass over the ␤APP-overexpressing muscle fibers (as if not receiving a proper signal from those muscle fibers). Note that the impaired innervation was not due to an effect on spinal cord neurons of ␤APP fragments released to the medium because treatment of control cultures with the conditioned medium did not alter innervation <ref type="bibr" target="#b47">47</ref> (McFerrin et al., to be published). Hence, this culture system provides an excellent experimental model to study the role of ␤APP and other proteins in formation and maintenance of the NMJ.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>PRION PROTEIN</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p>Cellular prion protein (PrP c ) is a normal brain constituent, 33-37 kDa, containing 253-254 amino acids. It is considered the precursor of the transmissible scrapie agent, namely, the pathologic prion protein scrapie, PrP sc , produced by a configurational change induced in the PrP c by the pathologic prion molecules (reviewed in reference 20). The normal functions of PrP c are uncertain. PrP c is probably on the outer surface of the plasmalemma, <ref type="bibr" target="#b50">50,</ref><ref type="bibr" target="#b51">51</ref> with a hypothesized role in cell-cell recognition, adhesion, or communication. <ref type="bibr" target="#b52">52,</ref><ref type="bibr" target="#b53">53</ref> PrP sc is a 33-37-kDa isoform of PrP c that is resistant to protease-K degradation. At least part of the brain PrP sc occurs as congophilic amyloid. It is found only in brains of scrapie-infected animals and in patients with Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker syndrome (GSS), and kuru. <ref type="bibr" target="#b19">20</ref> PrP c and PrP sc are encoded by the same gene. The amount of corresponding mRNA is the same in normal and scrapie-infected brain, <ref type="bibr" target="#b19">20</ref> suggesting that PrP sc is derived from normal PrP c . Proteinase K applied to PrP sc from scrapie-infected brain generates a 27-30-kDa digestion-resistant fragment called PrP <ref type="bibr" target="#b27">[27]</ref><ref type="bibr" target="#b28">[28]</ref><ref type="bibr" target="#b29">[29]</ref><ref type="bibr" target="#b30">[30]</ref> , whereas the PrP c of normal brain is completely digested by proteinase K. <ref type="bibr" target="#b19">20</ref> Therefore, PrP <ref type="bibr" target="#b27">[27]</ref><ref type="bibr" target="#b28">[28]</ref><ref type="bibr" target="#b29">[29]</ref><ref type="bibr" target="#b30">[30]</ref> , encoded by a normal cellular gene, is considered to be the disease-characteristic fraction of scrapie brain. <ref type="bibr" target="#b19">20</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>NMJs</head><p>We have demonstrated that, in normal human muscle fibers, both PrP and its mRNA are localized only at the NMJs. <ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b54">54</ref>  By immuno-EM, prominent loci of PrP immunoreactivity were present subjunctionally within the muscle fiber to a depth of 5-7 m; they were especially localized at the base of the junctional folds (FIGURE <ref type="figure" target="#fig_6">8</ref>). Intense PrP immunoreactivity was also present between the folds and attached in small clusters along the muscle-fiber side of the folds. In all those locations, PrP was on 5-8-nm filaments (FIGURE <ref type="figure">9</ref>). Thus, PrP is a part of the postsynaptic cytoskeleton, where it may help to maintain postsynaptic-fold geometry. We suggest that PrP may have an important, albeit unknown, function in normal junctional biology.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>IBMs</head><p>We have demonstrated that PrP and PrP-mRNA are accumulated in nonjunctional regions of abnormal muscle fibers of s-and h-IBM. <ref type="bibr" target="#b16">17,</ref><ref type="bibr" target="#b18">19</ref> Increased synthesis of cellular prion had not been previously reported in any human disease. <ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>UBIQUITIN</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p>Ubiquitin is a 76-amino-acid intracellular protein present in all eukaryocytes. It is thought to be responsible for targeting a selective breakdown of abnormal and shortlived normal proteins by an ATP-dependent pathway (reviewed in references 55 and  56). Ubiquitin also plays a role in basic cellular processes such as DNA repair and modification of cell-surface receptors. <ref type="bibr" target="#b55">55,</ref><ref type="bibr" target="#b56">56</ref> Ubiquitin is accumulated in senile plaques of Alzheimer's disease, in Lewy bodies of Parkinson's disease, and on abnormal inclusions in lower motor neurons of patients having amyotrophic lateral sclerosis (reviewed in references 57-59).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>NMJs</head><p>In normal human muscle, ubiquitin is localized postsynaptically at the NMJ where, by light microscopy, it closely colocalizes light-microscopically with bound ␣-BT and with desmin, <ref type="bibr" target="#b60">60</ref> indicating that it is located close to the AChRs.</p><p>Ubiquitin has been shown to be covalently linked to the lymphocyte homing receptor and to the receptor for platelet-derived growth factor. <ref type="bibr" target="#b61">61,</ref><ref type="bibr" target="#b62">62</ref> Because ubiquitination of membrane proteins appears to be highly selective, it has been proposed that a posttranslational receptor modification may play a role in signal transduction or in receptor processing. <ref type="bibr" target="#b61">61,</ref><ref type="bibr" target="#b63">63</ref> Therefore, similar ubiquitin-related mechanisms might be important at normal NMJs.</p><p>Binding of ubiquitin to receptor proteins has been postulated to be a contributory factor to an autoimmune response against the resulting molecular complex because a  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>FIGURE 9.</head><p>Gold immunoelectron-microscopy of PrP at a human NMJ. PrP is identified by 10-nm gold particles, ×63,000. In this particular electron micrograph illustrating a slightly obliquely cut NMJ, PrP is strongly immunolocalized between the folds and attached in small clusters (identified by arrows) along the muscle-fiber side of the folds. The NMJ and its postsynaptic folds are identified by the dark acetylcholinesterase reaction.</p><p>high percentage of patients with systemic lupus erythematosus have autoantibodies reacting with ubiquitin. <ref type="bibr" target="#b64">64</ref> What role ubiquitin may play in the normal biology or pathology of the human NMJ is not yet known. Hypothetically, it may be involved in a functional posttranslational modification of the AChR or other postsynaptic proteins, or in their intracellular degradation. In myasthenia gravis, ubiquitination of the AChR could be a facilitating factor associated with the anti-AChR antibody attack. Of interest would be to determine whether patients with myasthenia gravis have circulating antibodies against ubiquitin and whether localization of ubiquitin at the NMJs is abnormal in them. Because ubiquitin is covalently bound to proteins, affinity purification of putative AChR-ubiquitin complexes should be possible.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>IBMs</head><p>We have shown that ubiquitin is abnormally accumulated in nonjunctional regions of s-and h-IBM muscle fibers in several subcellular localizations, including 6-10nm filaments and PHFs. <ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b15">16</ref> ␣ 1 -ANTICHYMOTRYPSIN (␣ 1 -ACT) Background ␣ 1 -Antichymotrypsin (␣ 1 -ACT), a 68-kDa glycoprotein, is a serine protease inhibitor of the serpin superfamily (reviewed in reference 65). It preferentially inhibits cathepsin G, chymotrypsin, and mast cell chymases (reviewed in reference 66). ␣ 1 -ACT is secreted from the liver into the circulation, where it provides widespread functions to control unwanted proteolysis. ␣ 1 -ACT is an acute-phase protein because its concentration in plasma greatly increases after various types of stress. 66 ␣ 1 -ACT has been colocalized with ␤-amyloid protein in senile plaques of Alzheimer-disease brain. <ref type="bibr" target="#b67">67,</ref><ref type="bibr" target="#b68">68</ref> NMJs ␣ 1 -ACT was strongly immunolocalized at human and rat NMJs. <ref type="bibr" target="#b69">69</ref> At the NMJ, ␣ 1 -ACT closely colocalized with other postsynaptic components, including ␣-BT, ␤APP, desmin, and dystrophin. <ref type="bibr" target="#b69">69</ref>  The function(s) of ␣ 1 -ACT at the NMJ is not known. Possibly, it plays an important role in the housekeeping of various components of the postsynaptic cytoplasm, plasmalemma, and extracellular matrix. Since cathepsin G is accumulated at the NMJ, <ref type="bibr" target="#b70">70</ref> putatively ␣ 1 -ACT may, among its other functions, protect junctional proteins from cathepsin G-mediated breakdown of extracellular matrix and cellular components. <ref type="bibr" target="#b66">66,</ref><ref type="bibr" target="#b71">71,</ref><ref type="bibr" target="#b73">73</ref> A proposed function of another serine protease inhibitor, nexin I (PN-I), previously localized at mouse NMJs, <ref type="bibr" target="#b72">72</ref> is that it may inhibit extracellular matrix proteolysis potentially caused by plasminogen activator. <ref type="bibr" target="#b73">73</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>IBMs</head><p>We have reported accumulations of ␣ 1 -ACT in nonjunctional regions of abnormal muscle fibers of patients with inclusion-body myositis. <ref type="bibr" target="#b12">13</ref> In those abnormal muscle fibers, as in senile plaques of Alzheimer brain, ␣ 1 -ACT colocalized with the increased accumulations of ␤-amyloid protein. <ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b67">67,</ref><ref type="bibr" target="#b68">68</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>APOLIPOPROTEIN E (APOE) AND LOW-DENSITY LIPOPROTEIN RECEPTORS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p>ApoE is a multifunctional apolipoprotein composed of three isoforms, E2, E3, and E4, each encoded by a different allele of a single gene on chromosome 19. <ref type="bibr" target="#b74">74,</ref><ref type="bibr" target="#b75">75</ref> FIGURE 10. Double-labeling of human NMJs with antibodies against ␣ 1 -ACT (B,D) and ␣-BT (A,C), ×1200. There is a close colocalization between ␣ 1 -ACT and ␣-BT.</p><p>Its role in lipid transport is well known. Newer studies demonstrated that ApoE plays a role in various cellular events unrelated to lipid transport, including immunoregulation, modulation of cell growth and differentiation, <ref type="bibr" target="#b80">80</ref> and nerve regeneration. <ref type="bibr" target="#b76">76</ref> In Alzheimer's disease (AD), increased ApoE immunoreactivity occurs in amyloid plaques, neurofibrillary tangles, and the cytoplasm of abnormal neurons. <ref type="bibr" target="#b77">77,</ref><ref type="bibr" target="#b78">78</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>NMJs</head><p>Our original report demonstrating that ApoE is accumulated at normal human NMJs, <ref type="bibr" target="#b79">79</ref> subsequently confirmed by others, <ref type="bibr" target="#b89">89</ref> has been extended to emphasize its strictly postsynaptic localization there. <ref type="bibr" target="#b14">15</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>IBMs</head><p>Our recent studies demonstrated that ApoE is accumulated in abnormal muscle fibers in sporadic and hereditary IBM. <ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b14">15</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Low-Density Lipoprotein (LDL) Receptors</head><p>LDL receptors, which are muscle receptors for ApoE, are also immunolocalized and concentrated at the postsynaptic domain of human NMJs, according to our preliminary studies (Mirabella and Askanas, unpublished). The role of ApoE at the NMJ and the significance of increased LDL receptors there require elucidation. In s-IBM, the LDL receptors were increased in the vacuolated muscle fibers (Mirabella and  Askanas, unpublished).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>TRANSFORMING GROWTH FACTOR ␤1 (TGF-␤1)</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p>TGF-␤1 is a 25-kDa secretory peptide known to be a multifunctional regulator of cellular activity. <ref type="bibr" target="#b81">81,</ref><ref type="bibr" target="#b82">82</ref> Produced by a wide variety of cells and tissues, it is both a stimulator and inhibitor of cellular replication. TGF-␤1 modulates cell differentiation and extracellular matrix production in various cells and plays an important role in normal growth and development during embryogenesis and tissue repair after injury. It is a potent cytokine that possesses both proinflammatory and anti-inflammatory activities, such as suppression of T and B cell proliferation, inhibition of macrophage maturation, and activation of secretion of IgG and IgM by B cells. It has also been proposed that TGF-␤1 plays a role in myogenic development in culture. <ref type="bibr" target="#b83">83,</ref><ref type="bibr" target="#b84">84</ref> NMJs TGF-␤1 is accumulated at normal human NMJs <ref type="bibr" target="#b24">25</ref>  (Mirabella et al., to be published), where, by light microscopy, it colocalizes with ␣-BT, suggesting a postsynaptic location. Its role in the normal NMJ biology remains to be studied.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>IBMs</head><p>We have demonstrated that TGF-␤1 is abnormally accumulated in nonjunctional regions of IBM muscle fibers <ref type="bibr" target="#b24">25</ref>  (Mirabella et al., to be published). Its pathogenic role is not known.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>NEURONAL (n) AND INDUCIBLE (i) NITRIC OXIDE SYNTHASES (NOS), AND NITROTYROSINE</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p>Three forms of human NOS-neuronal, inducible, and endothelial-have been cloned and are encoded by different genes on chromosomes 12, 17, and 7, respectively (reviewed in references 85 and 86). Nitric oxide (NO) is a short-lived reactive gas formed by NOS directly from the guanidino nitrogen of L-arginine. <ref type="bibr" target="#b85">85,</ref><ref type="bibr" target="#b86">86</ref> NO is considered to be both an intercellular and intracellular messenger, having many diverse functions, such as playing a role in vasodilation, mediating antimicrobial toxicity of macrophages, serving as an interneuronal messenger, and possibly influencing transcriptional and posttranscriptional regulation of gene expression. <ref type="bibr" target="#b85">85,</ref><ref type="bibr" target="#b86">86</ref> In contrast to many human and animal tissues in which functions of the NOS and NO have been extensively studied, their role in normal and diseased human and animal skeletal muscle is just beginning to be analyzed. Excessive production of NO is postulated to play an important role in various diseases, including neurodegenerative, inflammatory, and immunological processes. <ref type="bibr" target="#b86">86</ref> The mechanisms by which NO may contribute to the pathogenesis of various diseases are not well understood, but one is thought to involve its ability to react with superoxide anion to form the highly reactive, extremely toxic molecule, peroxynitrite (reviewed in reference 87).</p><p>Peroxynitrite induces nitration of tyrosines in proteins, forming the stable component, 3-nitrotyrosine (NT). <ref type="bibr" target="#b87">87</ref> Presence of NT in tissues is considered indicative of NO-induced oxidative stress. <ref type="bibr" target="#b87">87</ref> NO has been reported (a) to be a messenger molecule for myoblast fusion <ref type="bibr" target="#b94">94</ref> and (b) to serve as a retrograde signal, generated by muscle, for activity-dependent suppression of the presynaptic component of the developing NMJ in Xenopus nerve-muscle cocultures. <ref type="bibr" target="#b95">95</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>NMJs</head><p>We have recently demonstrated in fresh-frozen sections that both nNOS and iNOS are strongly localized at the postsynaptic, but not the presynaptic, domain of normal human and rat NMJs <ref type="bibr" target="#b96">96</ref>  (FIGURES 11 and 12). By immuno-EM, the postsynaptic nNOS and iNOS are localized to variously sized filamentous and membranous structures. <ref type="bibr" target="#b96">96</ref> nNOS, but not iNOS, is closely colocalized with intermediate-filament desmin. <ref type="bibr" target="#b96">96</ref> iNOS was present in clusters not associated with desmin. <ref type="bibr" target="#b96">96</ref> The data from our studies do not agree with studies of others who reported that in various species, in fixed sections of muscle fibers, nNOS was localized exclusively at the sarcolemma, and it was either exclusively <ref type="bibr" target="#b89">89</ref> or predominantly <ref type="bibr" target="#b90">90</ref> present in type-II fibers. Other studies reported the following: (a) in fixed sections of frozen human and mouse muscle, nNOS is colocalized at the sarcolemma with dystrophin 91 (subsequently, in mouse skeletal muscle, the association of nNOS with the sarcolemma was postulated to be mediated by direct nNOS binding to ␣ 1 -syntrophin, a protein of the dystrophin complex containing a PDZ motif <ref type="bibr" target="#b92">92</ref> ) and (b) increased immunoreactivity  of nNOS, at adult mouse NMJs, which contrary to our results was postulated to be in the presynaptic domain. <ref type="bibr" target="#b93">93</ref> The functions of the increased concentrations of nNOS and iNOS at the postsynaptic domain of the NMJ and the mechanisms of their control are not known. Recently, it was reported that NO generated by nNOS selectively enhances Ca 2+ calmodulin-dependent phosphorylation of postsynaptic-density proteins in rat brain. <ref type="bibr" target="#b97">97</ref> iNOS ultrastructurally is not closely associated with desmin <ref type="bibr" target="#b96">96</ref> and its association with other junctional proteins is not known. In other situations, iNOS is mainly transcriptionally regulated and its synthesis can be stimulated by cytokines, inflammation, and other pathologic processes (reviewed in references 85, 86, and FIGURE 12. Double-immunofluorescence of human NMJs with antibodies against iNOS (A,C), dystrophin (B), and desmin (D), ×1200. iNOS colocalizes with dystrophin and desmin, but seems to occupy a smaller area than dystrophin and desmin. 98). In a clonal cell line of mouse muscle, induction of iNOS-mRNA by cytokines has been demonstrated. <ref type="bibr" target="#b99">99</ref> Because our most recent studies demonstrate increased accumulation of interleukin 1␤, 1␣, and 6 postsynaptically at human NMJs, <ref type="bibr" target="#b27">27</ref> it is possible that cytokines induce transcription of iNOS (and possibly of nNOS) at the NMJ. Alternatively, because a small amount of iNOS-mRNA was recently found to be constitutively present in some human tissues, including skeletal muscle, <ref type="bibr" target="#b100">100</ref> it is possible that the increased iNOS at the NMJ represents its constitutive expression there.</p><p>It is not known whether the main function of the NOSs at the NMJ is to generate NO to (a) serve as a transduction signal for normal function of the NMJ, (b) provide a retrograde signal from the postsynaptic muscle fiber to the presynaptic axonal tip, or (c) help maintain a junctional or parajunctional structural component. Close colocalization of nNOS with the muscle intermediate-filament desmin suggests an important structure-function relationship. Future studies are needed to address these and other questions regarding the function of NOSs at the NMJs of normal and diseased human muscle.</p><p>Apparently, at normal human NMJs, NO, the product of the NOSs, is not generated in toxic excess to combine with superoxide to produce a very toxic peroxynitrite because no nitrotyrosine, which would reflect abnormally nitrated proteins, was detectable there. <ref type="bibr" target="#b96">96</ref> We have demonstrated by light microscopy that, at NMJs of myasthenia gravis (MG) patients, there is only an abnormally thin band of nNOS immunoreactivity corresponding to a similarly abnormally thin band of desmin immunoreactivity, <ref type="bibr" target="#b96">96</ref> correlating with the flattening and disorganization typical of MG postsynaptic folds. <ref type="bibr" target="#b101">101</ref> Lack of a similar decrease of iNOS at the myasthenic NMJs 96 suggests a different mechanism of iNOS induction and/or maintenance at the NMJ. Whether either NOS, or both, plays a role in the NMJ pathology in MG is of potential importance and should be studied.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>IBMs</head><p>We have demonstrated that both nNOS and iNOS, as well as NT, are abnormally accumulated in nonjunctional regions of the vacuolated muscle fibers in sporadic IBM <ref type="bibr" target="#b88">88</ref> and hereditary IBM. 103</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>SUPEROXIDE DISMUTASE-1 (SOD1)</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p>Superoxide is an oxygen free-radical toxic by-product of various cellular metabolic reactions. SOD1 and other superoxide dismutases protect the cell against oxidative stress by catalyzing the dismutation of the toxic superoxide anion O 2 • -, as follows:</p><formula xml:id="formula_0">O 2 • -+ 2H + Ǟ H 2 O 2 + O 2 (and then catalase converts H 2 O 2 Ǟ H 2 O + O 2 ).</formula></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>NMJs</head><p>SOD1 immunoreactivity was increased at human NMJs, where by light microscopy it closely colocalized with ␣-BT, indicating a postsynaptic domain. <ref type="bibr" target="#b102">102</ref> Accumulation of SOD1 at normal human NMJs suggests a locally increased need to diminish superoxide anion. Superoxide in excess can combine with NO, produced by the iNOS and nNOS at the NMJ, to form the very toxic peroxynitrite, which can pathologically nitrate the tyrosine groups of proteins, the result evidenced as nitrotyrosine. However, at normal human NMJs, there appears to be adequate disposal of both superoxide and NO because nitrotyrosine immunoreactivity, which indicates pathologic nitration of proteins, was not increased there <ref type="bibr" target="#b96">96</ref> (in contrast to the presence of NT in nonjunctional regions of pathologic muscle fibers in inclusion-body myositis <ref type="bibr" target="#b88">88</ref> ). Therefore, "oxidative stress" evidenced by nitration of proteins 87 apparently does not take place at the normal human NMJ. The detailed molecular mechanisms responsible for the increased concentration of SOD1 at the NMJ require elucidation.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>IBMs</head><p>Recently, we demonstrated that SOD1 and its mRNA are accumulated in nonjunctional regions of abnormal IBM muscle fibers <ref type="bibr" target="#b102">102</ref>  (Askanas et al., to be published).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>HYPOTHESIS OF "JUNCTIONALIZATION" OF NONJUNCTIONAL REGIONS OF MUSCLE FIBERS IN INCLUSION-BODY MYOSITIS</head><p>On the preceding pages, we have described 14 proteins newly recognized to be accumulated at the normal human NMJ and not elsewhere in the muscle fiber. The normal phenomena of protein and mRNA accumulation at the NMJ have been termed by us as "junctionalization" (FIGURE <ref type="figure" target="#fig_0">13</ref>). <ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b7">8</ref> The postsynaptic proteins characteristic of junctionalization are induced, directly or indirectly, by the contacting motor-neuron axonal tip and presumably are governed, at least partially, by enhanced expression of the corresponding genes in muscle-fiber junctional (postsynaptic) nuclei, presumably modulated through yet-undelineated transcription factors. We have proposed a "junctionalizing master gene" whose product modulates transcription of the "junctional-protein genes". In the normal innervated mature muscle fiber, those junctional-protein genes are concurrently downregulated in the nonjunctional nuclei diffusely located in the vast nonjunctional regions of the muscle fiber (FIGURE <ref type="figure" target="#fig_0">13</ref>). It is of particular interest that all 14 of these newly described junctional proteins, and all 3 of their studied mRNAs, have been found by us to be pathologically accumulated in the nonjunctional regions of IBM muscle fibers (e.g., ␤APP, 10 prion, 17 ␣ 1 -ACT, <ref type="bibr" target="#b12">13</ref> FGF, <ref type="bibr" target="#b26">26</ref> TGF␤, <ref type="bibr" target="#b24">25</ref> ubiquitin, <ref type="bibr" target="#b15">16</ref> ApoE, <ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b14">15</ref> AChR, 43-kDa protein, 28 SOD1, <ref type="bibr" target="#b102">102</ref> iNOS and nNOS, <ref type="bibr" target="#b88">88</ref> and interleukins 1␣, 1␤, and 6 <ref type="bibr" target="#b27">27</ref> ). Thus, these accumulated "junctional/IBM proteins" and their corresponding increased "junctional/IBM-mRNAs" are the ones normally accumulated in the muscle fiber only at the postsynaptic region of the NMJ. We have therefore proposed the concept of "pathologic junctionalization" of extrajunctional regions of the IBM muscle fiber, causing altered gene expression of the FIGURE 13. Hypothetical "junctionalization" mechanism (ectopic expression of junctional proteins) in inclusion-body myositis. In nonjunctional nuclei of IBM, there is reactivation of genes of junctional proteins or downregulation of a gene (genes?) of junctional-protein suppression-factor (by virus?, abnormal aging?, genetic factors?, others).</p><p>"IBM-junctionalized" (previously normal nonjunctional) nuclei perhaps via the proposed junctionalizing master gene <ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b7">8</ref> (FIGURE <ref type="figure" target="#fig_0">13</ref>). Hypothetically, this junctionalization could be induced, directly or indirectly, by a putative virus in s-IBM or by a mutated-gene protein in h-IBM. <ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b7">8</ref> radic inclusion-body myositis (s-IBM), hereditary inclusion-body myopathy (h-IBM), and cultured human muscle after ␤-amyloid precursor protein (␤APP) gene transfer. </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>FIGURE 1 .</head><label>1</label><figDesc>FIGURE 1. Triple-labeling of human NMJs with ␣-BT, C-␤APP antibody, A␤ antibody, and antibodies against desmin and dystrophin, all ×1000. (A,B,C) ␣-BT, C-␤APP, and dystrophin; (D,E,F) ␣-BT, C-␤APP, and desmin; (G,H,I) ␣-BT, A␤, and dystrophin; (J,K,L) ␣-BT, A␤, and desmin. There is a close colocalization of C-␤APP and A␤ with the three established postsynaptic components of the postsynaptic domain of the NMJ, namely, ␣-BT, desmin, and dystrophin.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>FIGURE 4 .</head><label>4</label><figDesc>FIGURE 4. Horseradish peroxidase immunoelectron-microscopy of desmin at human NMJs, ×5600. Desmin is immunolocalized strictly postsynaptically.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>FIGURE 5 .</head><label>5</label><figDesc>FIGURE 5. ␤APP-mRNA at human NMJs. (A) In situ hybridization with the 751-␤APP-cRNA probe containing the KPI motif. (B) Acetylcholinesterase reaction on an adjacent section. Both ×650. ␤APP-mRNA is strongly increased at two NMJs identified by the acetylcholinesterase reaction.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>FIGURE 6 .</head><label>6</label><figDesc>FIGURE 6. AChR immunoreactivity and AChR-mRNA at human NMJs. (A) PAP immunocytochemistry of AChR using a monoclonal antibody. (B) In situ hybridization with AChR-cRNA probe. Both ×1200. There is strongly concentrated AChR immunoreactivity and AChR-mRNA at the human NMJ.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head></head><label></label><figDesc>FIGURE 7 illustrates postsynaptic immunolocalization of PrP. By light microscopy, the topographic pattern of PrP im-munoreactivity at the NMJs corresponded exactly to the localization of bound ␣-BT and also closely colocalized with the postsynaptically concentrated immunoreactivity of A␤, C-␤APP, desmin, ubiquitin, and dystrophin.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>FIGURE 7 .</head><label>7</label><figDesc>FIGURE 7. Double-labeling of human NMJs with antibodies against prion protein (PrP) and four other established junctional proteins. (A,C,E,G) PrP; (B) ␣-BT; (D) dystrophin; (F) desmin; (H) ubiquitin. (A,B,E,F,G,H) ×1200; (C,D) ×770. There is a close colocalization of PrP with the four other postsynaptic membrane components.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>FIGURE 8 .</head><label>8</label><figDesc>FIGURE 8. Gold immunoelectron-microscopy of PrP at human NMJs. PrP is identified by 10-nm gold particles, ×43,000. In this picture, PrP is immunolocalized subjunctionally at the base of and below the folds. The NMJ and its postsynaptic folds are identified by the dark acetylcholinesterase reaction.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head></head><label></label><figDesc>FIGURE 10 illustrates close colocalization of ␣ 1 -ACT with ␣-BT at human NMJs.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head>FIGURE 11 .</head><label>11</label><figDesc>FIGURE 11. Double-immunofluorescence of human NMJs with antibodies against nNOS (A,C), dystrophin (B), and desmin (D), ×850. There is a close colocalization of nNOS with dystrophin and desmin.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head>Neurology 46 :</head><label>46</label><figDesc>487. 103. YANG, C-C., R. B. ALVAREZ, W. K. ENGEL, S. L. HELLER &amp; V. ASKANAS. 1998. Nitric-oxide induced oxidative stress in autosomal recessive and dominant inclusion-body myopathies. Brain. In press.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>TABLE 1 .</head><label>1</label><figDesc>Comparison between IBM VMFs and NMJ a</figDesc><table><row><cell></cell><cell cols="2">Protein Accumulated ________________________</cell><cell cols="2">mRNA Increased ________________________</cell></row><row><cell></cell><cell>NMJ,</cell><cell>IBM,</cell><cell>NMJ,</cell><cell>IBM,</cell></row><row><cell></cell><cell>Postsynaptic</cell><cell>VMFs</cell><cell>Postsynaptic</cell><cell>VMFs</cell></row><row><cell>Similarities</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>nAChR</cell><cell>+</cell><cell>+</cell><cell>+</cell><cell>+</cell></row><row><cell>␤APP</cell><cell>+</cell><cell>+</cell><cell>+</cell><cell>+</cell></row><row><cell>prion</cell><cell>+</cell><cell>+</cell><cell>+</cell><cell>+</cell></row><row><cell>SOD1</cell><cell>+</cell><cell>+</cell><cell>0</cell><cell>+</cell></row><row><cell>43-kDa (rapsyn)</cell><cell>+</cell><cell>+</cell><cell></cell><cell></cell></row><row><cell>ubiquitin</cell><cell>+</cell><cell>+</cell><cell></cell><cell></cell></row><row><cell>nNOS</cell><cell>+</cell><cell>+</cell><cell></cell><cell></cell></row><row><cell>iNOS</cell><cell>+</cell><cell>+</cell><cell></cell><cell></cell></row><row><cell>␣ 1 -ACT</cell><cell>+</cell><cell>+</cell><cell>0</cell><cell>0</cell></row><row><cell>FGF</cell><cell>+</cell><cell>+</cell><cell></cell><cell></cell></row><row><cell>TGF-␤1</cell><cell>+</cell><cell>+</cell><cell></cell><cell></cell></row><row><cell>IL 1␣</cell><cell>+</cell><cell>+</cell><cell></cell><cell></cell></row><row><cell>IL 1␤</cell><cell>+</cell><cell>+</cell><cell></cell><cell></cell></row><row><cell>IL 6</cell><cell>+</cell><cell>+</cell><cell></cell><cell></cell></row><row><cell>ApoE</cell><cell>+</cell><cell>+</cell><cell>0</cell><cell>0</cell></row><row><cell>Differences</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>nitrotyrosine</cell><cell>0</cell><cell>+</cell><cell></cell><cell></cell></row><row><cell>phosphorylated tau</cell><cell>0</cell><cell>+</cell><cell></cell><cell></cell></row><row><cell>congophilia</cell><cell>0</cell><cell>+</cell><cell></cell><cell></cell></row></table><note>a NMJ = neuromuscular junction; IBM = inclusion-body myositis; VMFs = vacuolated muscle fibers.</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head></head><label></label><figDesc>17496632, 1998, 1, Downloaded from https://nyaspubs.onlinelibrary.wiley.com/doi/10.1111/j.1749-6632.1998.tb10908.x by University Of Illinois At Urbana Champaign, Wiley Online Library on [05/03/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head></head><label></label><figDesc>17496632, 1998, 1, Downloaded from https://nyaspubs.onlinelibrary.wiley.com/doi/10.1111/j.1749-6632.1998.tb10908.x by University Of Illinois At Urbana Champaign, Wiley Online Library on [05/03/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head></head><label></label><figDesc>17496632, 1998, 1, Downloaded from https://nyaspubs.onlinelibrary.wiley.com/doi/10.1111/j.1749-6632.1998.tb10908.x by University Of Illinois At Urbana Champaign, Wiley Online Library on [05/03/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</figDesc><table /></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="17496632" xml:id="foot_0">, 1998, 1, Downloaded from https://nyaspubs.onlinelibrary.wiley.com/doi/10.1111/j.1749-6632.1998.tb10908.x by University Of Illinois At Urbana Champaign, Wiley Online Library on [05/03/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGMENTS</head><p>Our research-team colleagues who participated in various aspects of the studies described were Masako Bilak, Massimiliano Mirabella, Jesse Yang, Piraye Serdaroglu, Janis McFerrin, Eva Sarkozi, and Kazuhiro Haginoya. We are grateful to Stanley C. Froehner, Jon Lindstrom, Angela Vincent, Dennis J. Selkoe, Stanley B. Prusiner, and Steven A. Johnson, and the late George G. Glenner, for their generous gifts of antibodies and cDNA probes. Assistance in photographic processing by Maggie Baburyan and in preparation of the manuscript by Lynne Martinez is appreciated.</p></div>
			</div>


			<div type="funding">
<div xmlns="http://www.tei-c.org/ns/1.0"><p>a Studies described in this paper were supported in part by the NIH, the Muscular Dystrophy Association, the Alzheimer Association, and the Sheldon Katz, Helen Lewis, and Ron Stever Research Funds.</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">The role of agrin in synapse formation</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Bowe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Fallon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu. Rev. Neurosci</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="443" to="462" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Retrograde signaling in the formation and maintenance of the neuromuscular junction</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Conner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Smith</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurobiol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="722" to="739" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Building synapses: agrin and dystroglycan stick together</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Fallon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">W</forename><surname>Hall</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">TINS</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="469" to="473" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Synaptic structure and development: the neuromuscular junction</title>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">H</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Sanes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuron</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="99" to="121" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
	<note>Cell</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Dystrophin-associated proteins and synapse formation: is ␣-dystroglycan the agrin receptor?</title>
		<author>
			<persName><forename type="first">R</forename><surname>Sealock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Froehner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="617" to="619" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Intercellular communication that mediates formation of the neuromuscular junction</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Daniels</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Neurobiol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="143" to="170" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">New advances in the understanding of sporadic inclusion-body myositis and hereditary inclusion-body myopathies</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr. Opin. Rheumatol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="486" to="496" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Newest approaches to diagnosis and pathogenesis of sporadic inclusion-body myositis and hereditary inclusion-body myopathies, including molecular-pathologic similarities to Alzheimer disease</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Inclusion-Body Myositis and Myopathies</title>
				<meeting><address><addrLine>London/New York</addrLine></address></meeting>
		<imprint>
			<publisher>Cambridge University Press</publisher>
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note>In press</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Light-and electron-microscopic localization of ␤-amyloid protein in muscle biopsies of patients with inclusion-body myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Pathol</title>
		<imprint>
			<biblScope unit="volume">141</biblScope>
			<biblScope unit="page" from="31" to="36" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">␤-Amyloid precursor epitopes in muscle fibers of inclusion-body myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Neurol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="551" to="560" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Twisted tubulofilaments of inclusion-body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Selkoe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Pathol</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="page" from="177" to="187" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mirabella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neuropathol. Exp. Neurol</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="774" to="786" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Strong immunoreactivity of ␣ 1 -antichymotrypsin colocalizes with ␤-amyloid protein and ubiquitin in vacuolated muscle fibers of inclusion-body myositis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neuropathol</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="378" to="382" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Apolipoprotein E immunoreactive deposits in inclusion-body muscle diseases</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mirabella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">Weisgraber</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">343</biblScope>
			<biblScope unit="page" from="364" to="365" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Apolipoprotein E and apolipoprotein E messenger RNA in muscle of inclusion-body myositis and myopathies</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mirabella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Weisgraber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Neurol</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="864" to="872" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Immunolocalization of ubiquitin in muscle biopsies of patients with inclusion-body myositis and oculopharyngeal muscular dystrophy</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Serdaroglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci. Lett</title>
		<imprint>
			<biblScope unit="volume">130</biblScope>
			<biblScope unit="page" from="73" to="76" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Prion protein is abnormally accumulated in inclusion-body myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M S</forename><surname>Tomé</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Leclerc</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">NeuroReport</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="25" to="28" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">␤-Amyloid precursor protein mRNA is increased in inclusion-body myositis muscle</title>
		<author>
			<persName><forename type="first">E</forename><surname>Sarkozi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neu-roReport</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="815" to="818" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Abnormal accumulation of prion protein mRNA in muscle fibers of patients with sporadic inclusion-body myositis and hereditary inclusion-body myopathy</title>
		<author>
			<persName><forename type="first">E</forename><surname>Sarkozi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Pathol</title>
		<imprint>
			<biblScope unit="volume">145</biblScope>
			<biblScope unit="page" from="1280" to="1284" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Molecular biology of prion and diseases</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Prusiner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">252</biblScope>
			<biblScope unit="page" from="1515" to="1522" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">The neurochemistry of prion diseases</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Dearmond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Prusiner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurochem</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="1589" to="1601" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Human prion diseases</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Prusiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Hsiao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Neurol</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="385" to="395" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">A cellular gene encodes scrapie PrP 27-30 protein</title>
		<author>
			<persName><forename type="first">B</forename><surname>Oesch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Westaway</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Walchli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Mckinley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B H</forename><surname>Kent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Aebersold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Barry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Tempst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Teplow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Hood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Prusiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Weissmann</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="735" to="746" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Increase of nitric oxide synthases and nitrotyrosine in inclusion-body myositis</title>
		<author>
			<persName><forename type="first">C-C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">NeuroReport</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="153" to="158" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<monogr>
		<title level="m" type="main">Transforming growth factor-beta 1 is abnormally accumulated in vacuolated muscle fibers of sporadic inclusion-body myositis and hereditary inclusion-body myopathy</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mirabella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
	<note>abstract</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Ann. Neurol</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="320" to="321" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Twisted tubulofilaments (TTFs) in inclusion-body myositis (IBM) muscle contain fibroblast growth factor (FGF) and its receptor (FGF-R)</title>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page">130</biblScope>
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
	<note>abstract</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Light-and electronmicroscopic immunolocalization of interleukins 1␣, 1␤, and 6 in vacuolated muscle fibers of sporadic inclusion-body myositis (s-IBM</title>
		<author>
			<persName><forename type="first">K</forename><surname>Haginoya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page">126</biblScope>
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Muscle nicotinic acetylcholine receptor (nAChR) and its associated protein 43 Kd (43K) are highly accumulated in vacuolated muscle fibers (VMFs) of inclusion-body myositis (IBM)</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Froehner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page">131</biblScope>
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
	<note>abstract</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Normal and abnormal biology of the ␤-amyloid precursor protein</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Selkoe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu. Rev. Neurosci</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="489" to="517" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">The precursor of Alzheimer&apos;s disease amyloid A4 protein resembles a cell-surface receptor</title>
		<author>
			<persName><forename type="first">J</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">G</forename><surname>Lermaine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Unterbeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Salbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Masters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Grzeschik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Multhaup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Beyreuther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Muller-Hill</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">325</biblScope>
			<biblScope unit="page" from="733" to="736" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Molecular cloning and characterization of a cDNA encoding the cerebrovascular and neuritic plaque amyloid peptides</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Robakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ramakrishna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wolfe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Wisniewski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. U.S.A</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="4190" to="4194" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Amyloid ␤ protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Tanzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Gusella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Watkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A P</forename><surname>Bruns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>St</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>George-Hyslop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Van Keuren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Patterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Pagan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Kurnit</surname></persName>
		</author>
		<author>
			<persName><surname>Neve</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">235</biblScope>
			<biblScope unit="page" from="880" to="884" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Tanzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Mcclatchey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Lamerti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Villa-Kamaroff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Gusella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Neve</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">331</biblScope>
			<biblScope unit="page" from="528" to="530" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Identification, biogenesis, and localization of precursors of Alzheimer&apos;s disease A4 amyloid protein</title>
		<author>
			<persName><forename type="first">A</forename><surname>Wiedemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Konig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bunke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Fisher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Salbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Masters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Beyreuther</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="115" to="126" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors</title>
		<author>
			<persName><forename type="first">R</forename><surname>Ponte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gonzalez-Dewhitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schilling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Greenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wallace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Lieberberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Fuller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Cordell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">331</biblScope>
			<biblScope unit="page" from="525" to="527" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Amyloid ␤-protein precursor is associated with extracellular matrix</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">G</forename><surname>Klier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Cole</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Stallcup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Schubert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Res</title>
		<imprint>
			<biblScope unit="volume">515</biblScope>
			<biblScope unit="page" from="336" to="342" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">The regulation of amyloid ␤ protein precursor secretion and its modulatory role in cell adhesion</title>
		<author>
			<persName><forename type="first">D</forename><surname>Schubert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L-W</forename><surname>Jin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Saitoh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Cole</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuron</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="689" to="694" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">␤-Amyloid precursor protein mediates neuronal cell-cell and cell-surface adhesion</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Breen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bruce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Anderton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurosci. Res</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="90" to="100" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Alzheimer&apos;s disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Shivers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hilbich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Multhaup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Salbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Beyreuther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>See-Burg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EMBO J</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="1365" to="1370" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Localization of Alzheimer ␤A4 amyloid precursor protein at central and peripheral synaptic sites</title>
		<author>
			<persName><forename type="first">W</forename><surname>Schubert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Prior</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wiedemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Dircksen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Multhaup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Masters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Beyreuther</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Res</title>
		<imprint>
			<biblScope unit="volume">563</biblScope>
			<biblScope unit="page" from="184" to="191" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Alzheimer&apos;s disease initial report of the purification and characteristics of a novel cerebrovascular amyloid protein</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Glenner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Wong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Biophys. Res. Commun</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="885" to="890" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Strong immunoreactivity of ␤-amyloid precursor protein, including the ␤-amyloid protein sequence, at human neuromuscular junctions</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci. Lett</title>
		<imprint>
			<biblScope unit="volume">143</biblScope>
			<biblScope unit="page" from="96" to="100" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Immunocytochemical localization of desmin at human neuromuscular junctions</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bornemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="949" to="953" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Local transcriptional control of utrophin expression at the neuromuscular synapse</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">O</forename><surname>Gramolini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Dennis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Tinsley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Robertson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cartaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Davies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Jasmin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">272</biblScope>
			<biblScope unit="page" from="8117" to="8120" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Transfer of ␤-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Baqué</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sarkozi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. U.S.A</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="1314" to="1319" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">␤APP gene transfer into cultured human muscle induces inclusion-body myositis aspects</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Baqué</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neu-roReport</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="2155" to="2158" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Overexpression of ␤-amyloid precursor protein (␤APP) gene in cultured normal human muscle using adenovirus vector prevents formation of neuromuscular junctions (NMJs) and functional innervation: relevance to inclusion-body myositis (s-IBM</title>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Baqué</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page">332</biblScope>
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Human muscle cultured in monolayer and co-cultured with fetal rat spinal cord</title>
		<author>
			<persName><forename type="first">T</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurosci</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="3131" to="3141" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">De novo neuromuscular junction formation on human muscle fibers cultured in monolayer and innervated by fetal rat spinal cord: ultrastructural and ultrastructural-cytochemical studies</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kwan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Martinuzzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>Hawkins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurocytol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="523" to="537" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene</title>
		<author>
			<persName><forename type="first">K</forename><surname>Basler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Oesch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Westaway</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Walchli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Groth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Mckin-Ley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Prusiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Weissmann</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="417" to="428" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Antibodies to a scrapie prion protein</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Bendheim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Barry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Dearmond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Stites</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Prusiner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">310</biblScope>
			<biblScope unit="page" from="418" to="421" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Purification and partial characterization of the normal cellular homologue of the scrapie agent protein</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Bendheim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Potempska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Kascsak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Bolton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Infect. Dis</title>
		<imprint>
			<biblScope unit="volume">158</biblScope>
			<biblScope unit="page" from="1198" to="1208" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Cellular isoform of the scrapie agent protein participates in lymphocyte activation</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">R</forename><surname>Cashman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Loertscher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nalbantoglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Shaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Kascsak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Bolton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Bendheim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="185" to="192" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Prion protein is strongly immunolocalized at the postsynaptic domain of human normal neuromuscular junctions</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Leclerc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M S</forename><surname>Tomé</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci. Lett</title>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="page" from="111" to="114" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">The ubiquitin system: functions and mechanisms</title>
		<author>
			<persName><forename type="first">D</forename><surname>Finley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Varsharsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">TIBS</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="343" to="347" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">The ubiquitin pathway for the degradation of intracellular proteins</title>
		<author>
			<persName><forename type="first">A</forename><surname>Herskho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ciechanover</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Prog. Nucleic Acid Res. Mol. Biol</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="19" to="56" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Ubiquitous variations in nerves</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Gallo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Anderton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">337</biblScope>
			<biblScope unit="page" from="687" to="688" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Mechanisms of muscle wasting: the role of the ubiquitin-proteasome pathway</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">E</forename><surname>Mitch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Goldberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N. Engl. J. Med</title>
		<imprint>
			<biblScope unit="volume">335</biblScope>
			<biblScope unit="page" from="1897" to="1905" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Ubiquitin, cell stress, and disease of the nervous system</title>
		<author>
			<persName><forename type="first">J</forename><surname>Lowe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Mayer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropathol. Appl. Neurobiol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="281" to="291" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Immunocytochemical localization of ubiquitin at human neuromuscular junctions</title>
		<author>
			<persName><forename type="first">P</forename><surname>Serdaroglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropathol. Appl. Neurobiol</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="232" to="236" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Yarden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Escobedo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Kuang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yang-Fent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">O</forename><surname>Daniel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Tremble</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ehen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ando</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Harkens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Franke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Fried</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">T</forename><surname>Williams</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">323</biblScope>
			<biblScope unit="page" from="226" to="232" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Cell surface molecule associated with lymphocyte homing is a ubiquitinated branched-chain glycoprotein</title>
		<author>
			<persName><forename type="first">M</forename><surname>Siegelman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Bond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Gallatin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">St</forename><surname>John</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">T</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Fried</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">L</forename><surname>Weissmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">231</biblScope>
			<biblScope unit="page" from="823" to="829" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Ubiquitin has intrinsic proteolytic activity: implications for cellular regulation</title>
		<author>
			<persName><forename type="first">V</forename><surname>Fried</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">T</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hildebrandt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">Weiner</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. U.S.A</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="3685" to="3689" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Presence of antibodies to ubiquitin during the autoimmune response associated with systemic lupus erythematosus</title>
		<author>
			<persName><forename type="first">S</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-P</forename><surname>Briand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H V</forename><surname>Van Regenmortel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. U.S.A</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="8176" to="8180" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Serpins: the superfamily of plasma serine protease inhibitors</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Carrel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Travis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Protease Inhibitors</title>
				<meeting><address><addrLine>Amsterdam/New York</addrLine></address></meeting>
		<imprint>
			<publisher>Elsevier</publisher>
			<date type="published" when="1987">1987</date>
			<biblScope unit="page" from="403" to="420" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Human plasma proteinase inhibitors</title>
		<author>
			<persName><forename type="first">J</forename><surname>Travis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Salvesen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu. Rev. Biochem</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="655" to="709" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Immunochemical identification of the serine protease inhibitor ␣ 1 -antichymotrypsin in the brain amyloid deposits of Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Abraham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Selkoe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Potter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="487" to="501" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">␣ 1 -Antichymotrypsin is associated solely with amyloid deposits containing the ␤-protein: amyloid and cell localization of ␣ 1 -antichymotrypsin</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Abraham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Shirahara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Potter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurobiol. Aging</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="123" to="129" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Alpha1-antichymotrypsin is strongly immunolocalized at normal human and rat neuromuscular junctions</title>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Synapse</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="280" to="283" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Strong immunoreactivity of serine proteinase inhibitor (serpin) alpha-1-antichymotrypsin (␣ 1 -ACT) at the postsynaptic domain (PSD) of human and rat neuromuscular junctions (NMJs)</title>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Biol. Cell</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">255</biblScope>
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Abnormal expression of a serine protease in human dystrophic muscle</title>
		<author>
			<persName><forename type="first">N</forename><surname>Katunuma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Yasogawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Sanada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kiwai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Miyoshi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biochem</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="625" to="628" />
			<date type="published" when="1978">1978</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Plasminogen activators and inhibitors in the neuromuscular system. III. The serpin protease nexin I is synthesized by muscle and localized at neuromuscular synapses</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Festoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Rao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hantai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Cell. Physiol</title>
		<imprint>
			<biblScope unit="volume">147</biblScope>
			<biblScope unit="page" from="76" to="86" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Plasminogen activators and inhibitors: roles in muscle and neuromuscular regeneration. Prog</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Festoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hantai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Res</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="423" to="431" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">Apolipoprotein E: cholesterol transport protein with expanding role in cell biology</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Mahley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">240</biblScope>
			<biblScope unit="page" from="622" to="630" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Apolipoprotein E: structure-function relationships</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Weisgraber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv. Protein Chem</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="249" to="302" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Expression of apolipoprotein E during nerve degeneration and regeneration</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Ignatius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Gebicke-Harter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Skene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Schilling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Weisgraber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Mahley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Shooter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. U.S.A</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="1125" to="1129" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer&apos;s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Namba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tomonaga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kawasaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Otomo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ikeda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Res</title>
		<imprint>
			<biblScope unit="volume">541</biblScope>
			<biblScope unit="page" from="163" to="166" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Einstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Weisgraber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Strittmatter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Saunders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pericak-Vance</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Schmechel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neuropathol. Exp. Neurol</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="535" to="544" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">Immunocytochemical localization of apolipoprotein E (ApoE) in inclusion-body myositis (IBM)</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mirabella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Weisgraber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page">347</biblScope>
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
	<note>abstract</note>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">Apolipoprotein E expression at neuromuscular junctions in mouse, rat, and human skeletal muscle</title>
		<author>
			<persName><forename type="first">M</forename><surname>Akaaboune</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Villanova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Festoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Verdiere-Sahuque</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hantai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS Lett</title>
		<imprint>
			<biblScope unit="volume">351</biblScope>
			<biblScope unit="page" from="246" to="248" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">Transforming growth factor-beta: biological function and chemical structure</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Sporn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Wakefield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Assoian</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">233</biblScope>
			<biblScope unit="page" from="532" to="534" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">Transforming growth factor beta: recent progress and new challenges</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Sporn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Roberts</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="page" from="1017" to="1021" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">Type beta transforming growth factor is an inhibitor of myogenic differentiation</title>
		<author>
			<persName><forename type="first">J</forename><surname>Massegue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cheifetz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Endo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Nadal-Ginard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. U.S.A</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="8206" to="8210" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main">Transforming growth factor B induces myoblast differentiation in the presence of mitogens</title>
		<author>
			<persName><forename type="first">A</forename><surname>Zentella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Massegue</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. U.S.A</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page" from="5176" to="5180" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main">Gases as biological messengers: nitric oxide and carbon monoxide in the brain</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Dawson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Synder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurosci</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="5147" to="5159" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main">Regulation of biosynthesis of nitric oxide</title>
		<author>
			<persName><forename type="first">C</forename><surname>Nathan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q-W</forename><surname>Xie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">269</biblScope>
			<biblScope unit="page" from="13725" to="13728" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main">The role of peroxynitrite in nitric oxide-mediated toxicity</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Crow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Beckman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Current Topics in Microbiology and Immunology: The Role of Nitric Oxide in Physiology and Pathophysiology</title>
				<meeting><address><addrLine>Berlin/New York</addrLine></address></meeting>
		<imprint>
			<publisher>Springer-Verlag</publisher>
			<date type="published" when="1995">1995</date>
			<biblScope unit="volume">196</biblScope>
			<biblScope unit="page" from="57" to="73" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main">Increase of nitric oxide synthases and nitrotyrosine in inclusion-body myositis</title>
		<author>
			<persName><forename type="first">C-C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">NeuroReport</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="153" to="158" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main">Nitric oxide in skeletal muscle</title>
		<author>
			<persName><forename type="first">L</forename><surname>Kobzik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Reid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Bredt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Stamier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">372</biblScope>
			<biblScope unit="page" from="546" to="548" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main">Species-independent expression of nitric oxide synthase in the sarcolemma region of visceral and somatic striated muscle fibers</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Grozdanovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Nakos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Dahrmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Mayer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gossrau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Tissue Res</title>
		<imprint>
			<biblScope unit="volume">281</biblScope>
			<biblScope unit="page" from="493" to="499" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main">Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Brenman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Chao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Xia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Aldape</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Bredt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="743" to="752" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main">Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and ␣ 1 -syntrophin mediated by PDZ domains</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Brenman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Chao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Gee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Mcgee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Craven</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Santillano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Xia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Froehner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Bredt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="757" to="767" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b93">
	<analytic>
		<title level="a" type="main">Accumulation of NO synthase (type-1) at the neuromuscular junctions in adult mice</title>
		<author>
			<persName><forename type="first">L</forename><surname>Oliver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Goureau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Courtois</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vigny</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">NeuroReport</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="924" to="926" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main">Nitric oxide as a messenger molecule for myoblast fusion</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Y</forename><surname>Baek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">Y</forename><surname>Moon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Ha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M-S</forename><surname>Kang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">269</biblScope>
			<biblScope unit="page" from="14371" to="14374" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main">Nitric oxide mediates activity-dependent synaptic suppression at developing neuromuscular synapses</title>
		<author>
			<persName><forename type="first">T</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">374</biblScope>
			<biblScope unit="page" from="262" to="266" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main">Immunolocalization of nitric oxide synthases at the postsynaptic domain of human and rat neuromuscular junctions-light and electron microscopic studies</title>
		<author>
			<persName><forename type="first">C-C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Haun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp. Neurol</title>
		<imprint>
			<biblScope unit="volume">148</biblScope>
			<biblScope unit="page" from="34" to="44" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b97">
	<analytic>
		<title level="a" type="main">Nitric oxide increases calcium/calmodulin-dependent phosphorylation of proteins in the postsynaptic density of adult rat cerebral cortex</title>
		<author>
			<persName><forename type="first">K</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-L</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Suen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y-U</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">T J</forename><surname>Mount</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Brain Res</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="22" to="26" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main">Nitric oxide synthase isozymes: characterization, purification, molecular cloning, and functions</title>
		<author>
			<persName><forename type="first">U</forename><surname>Förstermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">I</forename><surname>Closs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Pollock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nakane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Schwarz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Gath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kleinert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="1121" to="1131" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main">Cytokine-induced expression of nitric oxide synthase in C2C12 skeletal muscle myocytes</title>
		<author>
			<persName><forename type="first">G</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Becker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Prager</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">P</forename><surname>Giroir</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Physiol</title>
		<imprint>
			<biblScope unit="volume">267</biblScope>
			<biblScope unit="page" from="1020" to="1025" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main">Constitutive expression and structural diversity of inducible isoform of nitric oxide synthase in human tissues</title>
		<author>
			<persName><forename type="first">C-S</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Krishna</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Life Sci</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="219" to="225" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main">The fine structure of myasthenic neuromuscular junction</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">I</forename><surname>Zacks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Bauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Blumberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neuropathol. Exp. Neurol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="335" to="347" />
			<date type="published" when="1962">1962</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b102">
	<monogr>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sarkozi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Siddique</surname></persName>
		</author>
		<title level="m">Superoxide-dismutase-1 (SOD1) gene and protein in vacuolated muscle fibers of spo</title>
				<imprint>
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
